Weekly Roundup: Glanbia launches share buy-back program, Sabinsa scores Mexican patent

Related Articles

FormattedPicture

BUSINESS NEWS

This week in nutrition news, a successful ingredient examination period resulted in in-process patents in Canada and South Korea of NattoPharma’s MenaQ7 Vitamin... Read More

FormattedPicture

BUSINESS NEWS

This week in nutrition news, Norwegian vitamin K2 expert Kappa Bioscience launched a program to lower greenhouse emissions. Sabinsa increased its presence in the UK and... Read More

FormattedPicture

BUSINESS NEWS

This week in nutrition news, DSM sites in North America will be powered entirely by 100 percent renewable energy after a Power Purchase Agreement (PPA) with... Read More

FormattedPicture

BUSINESS NEWS

Glanbia and BioGaia have each released their financial results for the first half of 2021. While factors relating to the COVID-19 pandemic decreased BioGaia’s... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Deerland Probiotics and Enzymes’ latest study reveals its spore-forming probiotic Bacillus subtilis DE111 survives and replicates throughout the small intestine.

trans